Home / Contract Awards / FDA Selects Four Firms to Develop Automated Biological Product Reporting Methods

FDA Selects Four Firms to Develop Automated Biological Product Reporting Methods

The Food and Drug Administration has awarded four companies contracts worth up to $75M each to develop automated methods for reporting adverse drug events.

IBM (NYSE: IBM), Acumen, Dovel Technologies and IQVIA Government Solutions will use artificial intelligence, machine learning, natural language processing and other automation techniques to create data collection and analysis systems for the FDA’s Center for Biologics Evaluation and Research, the agency said Thursday in a FedBizOpps notice.

FDA requires each contractor to offer indirect access to medical information of U.S. patients, including administrative and claims data and electronic health records.

The indefinite delivery/indefinite quantity contracts have a five-year ordering period.

The agency also selected the four companies to develop surveillance tools as part of the Biologics Effectiveness and Safety Initiative.

Check Also

AASKI Gets $673M Army RS3 Task Order for Sensor Operations, Maintenance Support

AASKI Tehcnology will help the U.S. Army operate and maintain sensors under a potential $673M task order awarded through the service branch's Responsive Strategic Sourcing for Services contract vehicle.

Microsoft Announces $1B Investment in OpenAI to Bring AI Supercomputing Tech to Azure

Microsoft (Nasdaq: MSFT) will invest $1B in San Francisco-based artificial intelligence research company OpenAI to create new AI supercomputing technologies on the Azure cloud platform under a multiyear partnership.